Secretory Leukocyte Protease Inhibitor Inhibits Infection of Monocytes and Lymphocytes with Human Immunodeficiency Virus Type 1 but Does Not Interfere with Transcytosis of Cell-Associated Virus across Tight Epithelial Barriers

In the present study, we demonstrate that recombinant human secretory leukocyte protease inhibitor (rhSLPI) inhibits infection of lymphocyte- and monocyte-derived tumor cell lines and peripheral blood lymphocytes with laboratory-adapted isolates and with the primary isolate, NDK, of free human immun...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Clin Diagn Lab Immunol
Principais autores:	Hocini, Hakim, Becquart, Pierre, Bouhlal, Hicham, Adle-Biassette, Homa, Kazatchkine, Michel D., Bélec, Laurent
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 2000
Assuntos:	Cellular Immunology
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC95905/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10799472/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/cdli.7.3.515-518.2000
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!